News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
729,961 Results
Type
Article (41622)
Company Profile (294)
Press Release (688031)
Multimedia
Podcasts (94)
Webinars (20)
Section
Business (205898)
Career Advice (2040)
Deals (35705)
Drug Delivery (123)
Drug Development (81712)
Employer Resources (173)
FDA (16532)
Job Trends (15029)
News (348255)
Policy (32888)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2606)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (50006)
ALS (193)
Alzheimer's disease (1745)
Antibody-drug conjugate (ADC) (369)
Approvals (16844)
Artificial intelligence (601)
Autoimmune disease (223)
Automation (50)
Bankruptcy (367)
Best Places to Work (11665)
BIOSECURE Act (21)
Biosimilars (202)
Biotechnology (191)
Bladder cancer (178)
Brain cancer (63)
Breast cancer (687)
Cancer (5299)
Cardiovascular disease (446)
Career advice (1728)
Career pathing (39)
CAR-T (299)
CDC (54)
Celiac Disease (2)
Cell therapy (802)
Cervical cancer (41)
Clinical research (70380)
Collaboration (1906)
Company closure (4)
Compensation (1254)
Complete response letters (69)
COVID-19 (2741)
CRISPR (99)
C-suite (979)
Cystic fibrosis (149)
Data (7024)
Decentralized trials (3)
Denatured (31)
Depression (154)
Dermatology (57)
Diabetes (550)
Diagnostics (6858)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (296)
Drug pricing (195)
Drug shortages (29)
Duchenne muscular dystrophy (266)
Earnings (91210)
Editorial (59)
Employer branding (21)
Employer resources (152)
Events (118948)
Executive appointments (1036)
FDA (19938)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1621)
Gene editing (215)
Generative AI (52)
Gene therapy (657)
GLP-1 (1020)
Government (4710)
Grass and pollen (6)
Guidances (396)
Healthcare (18960)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (279)
Immuno-oncology (81)
Indications (156)
Infectious disease (3058)
Inflammatory bowel disease (203)
Inflation Reduction Act (16)
Influenza (130)
Intellectual property (273)
Interviews (316)
IPO (16692)
IRA (52)
Job creations (3683)
Job search strategy (1441)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (564)
Leadership (34)
Legal (7990)
Liver cancer (97)
Longevity (28)
Lung cancer (711)
Lymphoma (405)
Machine learning (52)
Management (59)
Manufacturing (912)
MASH (176)
Medical device (13897)
Medtech (13974)
Mergers & acquisitions (20159)
Metabolic disorders (1415)
mRNA (175)
Multiple sclerosis (172)
NASH (17)
Neurodegenerative disease (381)
Neuropsychiatric disorders (96)
Neuroscience (3133)
Neurotech (1)
NextGen: Class of 2026 (6570)
Non-profit (4541)
Now hiring (73)
Obesity (666)
Opinion (278)
Ovarian cancer (184)
Pain (228)
Pancreatic cancer (256)
Parkinson's disease (336)
Partnered (35)
Patents (550)
Patient recruitment (585)
Peanut (60)
People (59630)
Pharmaceutical (62)
Pharmacy benefit managers (31)
Phase 1 (21956)
Phase 2 (30975)
Phase 3 (23081)
Pipeline (7040)
Policy (305)
Postmarket research (2567)
Preclinical (9316)
Press Release (64)
Prostate cancer (274)
Psychedelics (49)
Radiopharmaceuticals (302)
Rare diseases (994)
Real estate (6015)
Recruiting (70)
Regulatory (25048)
Reports (54)
Research institute (2416)
Resumes & cover letters (354)
Rett syndrome (32)
RNA editing (20)
RSV (85)
Schizophrenia (160)
Series A (274)
Series B (201)
Service/supplier (13)
Sickle cell disease (110)
Special edition (22)
Spinal muscular atrophy (164)
Sponsored (45)
Startups (3693)
State (2)
Stomach cancer (18)
Supply chain (117)
Tariffs (85)
The Weekly (61)
Vaccines (1059)
Venture capital (101)
Weight loss (424)
Women's health (108)
Worklife (19)
Date
Today (93)
Last 7 days (642)
Last 30 days (2749)
Last 365 days (30185)
2026 (7807)
2025 (30376)
2024 (35375)
2023 (40215)
2022 (51332)
2021 (55879)
2020 (54204)
2019 (46719)
2018 (35170)
2017 (32271)
2016 (31674)
2015 (37761)
2014 (31487)
2013 (26536)
2012 (28799)
2011 (29476)
2010 (27569)
Location
Africa (742)
Alabama (89)
Alaska (7)
Arizona (328)
Arkansas (13)
Asia (39774)
Australia (6508)
California (12263)
Canada (3498)
China (1221)
Colorado (521)
Connecticut (519)
Delaware (364)
Europe (85920)
Florida (1845)
Georgia (392)
Hawaii (3)
Idaho (63)
Illinois (958)
India (79)
Indiana (558)
Iowa (22)
Japan (484)
Kansas (130)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1482)
Massachusetts (8765)
Michigan (344)
Minnesota (677)
Mississippi (6)
Missouri (137)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (83)
New Jersey (3259)
New Mexico (30)
New York (3216)
North Carolina (1554)
North Dakota (8)
Northern California (6065)
Ohio (363)
Oklahoma (23)
Oregon (42)
Pennsylvania (2468)
Puerto Rico (25)
Rhode Island (51)
South America (1115)
South Carolina (75)
South Dakota (1)
Southern California (4807)
Tennessee (199)
Texas (1925)
United States (43383)
Utah (365)
Vermont (1)
Virginia (293)
Washington D.C. (81)
Washington State (985)
West Virginia (4)
Wisconsin (117)
Wyoming (2)
729,961 Results for "flagship biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
In his annual letter, Flagship Pioneering’s Noubar Afeyan lays out a choice between near-term “human-made miracles” and a reversion to the pain and suffering of past diseases due to “growing contempt” in the U.S. for the scientific method.
January 12, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
March 9, 2026
·
4 min read
Press Releases
bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung
March 13, 2026
·
15 min read
Press Releases
Forte Biosciences, Inc. Announces 2025 Results and Provides Update
April 1, 2026
·
7 min read
Press Releases
Allosteric Bioscience, Inc. Targets Extending Longevity
March 5, 2026
·
1 min read
Press Releases
Novartis breaks ground on flagship manufacturing hub in North Carolina
December 12, 2025
·
7 min read
Press Releases
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
March 30, 2026
·
7 min read
Press Releases
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
March 13, 2026
·
8 min read
Press Releases
Novartis announces plans to build flagship manufacturing hub in North Carolina
November 20, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules - March 17, 2026
March 18, 2026
·
1 min read
1 of 72,997
Next
